Stay updated on REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNo significant additions or deletions are visible in the two screenshots; the page content and layout appear unchanged.SummaryDifference0.2%

- Check30 days agoChange DetectedUpdate includes a status notice about government funding and operating status plus a new version tag (v3.2.0); the old version tag (v3.1.0) was removed.SummaryDifference2%

- Check38 days agoChange Detected- Updated the page version from v3.0.2 to v3.1.0. Minor overall impact, mainly reflects a version increment.SummaryDifference0.0%

- Check52 days agoChange DetectedPage now shows Revision: v3.0.2 and the Back to Top link was removed; no substantive content changes detected.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has updated its facility locations, reducing the total number of study locations from 90 to 89, and has added new medical conditions related to immunoproliferative and lymphatic diseases. Additionally, the revision number has been updated to v3.0.0.SummaryDifference5%

Stay in the know with updates to REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.